Endocrinology in Saudi Arabia: AI Documentation for Gestational Diabetes

Category: Specialty Clinical | Market: Saudi Arabia | Keywords: endocrinology Saudi Arabia AI documentation gestational diabetes scribe GDM

Gestational diabetes mellitus (GDM) is a significant and growing clinical challenge in Saudi Arabia. The Kingdom has one of the highest rates of type 2 diabetes globally, and its GDM prevalence reflects this underlying metabolic vulnerability: estimates suggest 13–20% of Saudi pregnancies are complicated by gestational diabetes, making it one of the most common obstetric complications managed by Saudi endocrinology and obstetrics teams. The dual impact of GDM — immediate pregnancy complications including macrosomia, shoulder dystocia, and neonatal hypoglycaemia, and long-term maternal risk of developing type 2 diabetes within 5–10 years — makes GDM management a high-priority clinical programme in Saudi maternal health services.

GDM documentation requirements span the spectrum from initial diagnosis and risk stratification through intensive glycaemic monitoring management, insulin initiation and dose optimisation, delivery planning, and post-partum diabetes screening follow-up. AI medical scribing platforms configured for endocrinology and maternal diabetes management can substantially reduce the documentation burden on Saudi endocrinologists and obstetric physicians managing this high-volume, longitudinal clinical population.

## GDM Diagnosis and Initial Assessment Documentation

GDM diagnosis in Saudi Arabia follows WHO or IADPSG criteria, with oral glucose tolerance test (OGTT) interpretation at 24–28 weeks gestation. Initial GDM assessment documentation requires: OGTT result recording, risk factor assessment (BMI, family history of diabetes, previous GDM or macrosomic infant, PCOS), baseline glycaemic assessment (HbA1c if indicated), comorbidity documentation, and initial management plan (dietary counselling, blood glucose monitoring instruction, glycaemic targets). AI scribing platforms used in Saudi GDM clinics capture this structured initial assessment from the endocrinologist's verbal consultation, ensuring that all required documentation elements are present in the first encounter record.

## Glycaemic Monitoring and Insulin Management

GDM management documentation through the third trimester requires frequent follow-up records that capture: glucose diary review (fasting and post-prandial targets, number of out-of-range readings), current dietary and physical activity adherence assessment, weight gain trajectory, fetal growth documentation correlation, insulin dose if initiated (type, dose, timing with dose adjustment rationale), hypoglycaemia episode assessment, and glycaemic target assessment. AI scribing platforms that recognise insulin dose vocabulary — "14 units neutral protamine Hagedorn at bedtime, increased from 10 due to persistent fasting hyperglycaemia above 5.3" — generate accurate medication documentation from verbal assessment without the risk of transcription errors in dose recording.

## Delivery Planning Documentation

Pre-delivery GDM documentation in Saudi maternity hospitals requires: delivery planning discussion record (timing, mode, glucose management during labour protocol), communication with obstetric team, neonatology notification for neonatal hypoglycaemia monitoring, and insulin dose management plan for the peripartum period. AI scribing platforms used in pre-delivery endocrinology consultations capture the multidisciplinary planning discussion content and generate the structured pre-delivery endocrinology note that guides the obstetric and neonatology teams through delivery.

## Post-Partum Diabetes Screening and Long-Term Follow-Up

Post-partum GDM follow-up is critically important for early detection of type 2 diabetes conversion — a key clinical priority given Saudi Arabia's diabetes burden. Documentation of post-partum OGTT at 6 weeks and annual fasting glucose thereafter, along with lifestyle intervention counselling documentation for women with persistent glucose abnormality or pre-diabetes, constitutes an important preventive medicine record. AI scribing platforms that generate structured post-partum follow-up documentation support the longitudinal diabetes prevention pathway that evidence shows reduces the risk of type 2 diabetes conversion in women with prior GDM.

## Conclusion

Saudi endocrinologists and obstetric physicians managing gestational diabetes benefit from AI scribing platforms configured for the specific documentation requirements of maternal diabetes management. The combination of structured glycaemic monitoring documentation, accurate insulin dose recording, delivery planning notes, and post-partum screening follow-up addresses the full documentation lifecycle of GDM management. As Saudi Arabia continues to prioritise maternal health as a Vision 2030 objective, AI documentation support for the high-volume GDM programme will be an important component of sustainable endocrinology service capacity.

Internal links: Obstetrics Saudi Arabia AI Notes High-Risk Pregnancy, PCOS Management UAE Saudi Arabia AI Documentation Reproductive Health, Fasting Blood Sugar Monitoring Ramadan AI Notes, Thyroid Disease GCC Women AI Notes